Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve metal contamination risks in 2-trifluoromethyl quinoline production. Our green, catalyst-free process ensures high purity and scalable manufacturing for drug development.
Eliminate heavy metal catalysts and nitrogen protection in pyrazole synthesis. Scale to 100MT/yr with 99% purity for drug development.
Solve low yield & high cost in fexuprazan intermediate production. New route with >50% yield, 50% cost reduction. Scale to 100MT/yr.
Discover how ruthenium-catalyzed 3+2 cycloaddition enables efficient, single-step pyrrole synthesis with 50-71% yields, reducing multi-step costs and supply chain risks for pharmaceutical intermediates.
Solve deuterated compound synthesis challenges with this palladium-catalyzed method. High deuteration rates, cost-effective reagents, and broad functional group tolerance. Optimize your API supply chain.
Discover a novel antitumor compound synthesis with 92-99% yield, mild conditions, and strong HONE-1 cytotoxicity. Optimize your drug development supply chain.
Reduce production costs and environmental impact with >98% ee and 92% yield in asymmetric synthesis of key florfenicol intermediate for pharmaceutical manufacturing.
Solve supply chain risks with this 95% yield palladium-catalyzed method for 3-arylquinoline-2(1H) ketone. Cheap reagents, broad functional group tolerance, and simple post-processing for pharma intermediates.
Solve 1,2,4-triazole synthesis challenges: 97% yield, no heavy metals, no anhydrous conditions. Reduce R&D costs and supply chain risks for API manufacturing.
Discover efficient chiral indolo-dihydropyridoindole synthesis with 96% yield and 95% ee. Ideal for pharmaceutical R&D and cancer drug development. Scale up with CDMO expertise.
Discover a safer, scalable route for 2-trifluoromethyl quinazolinone derivatives. Avoid toxic CO, reduce costs, and ensure high purity for your pharmaceutical intermediates. Contact us for custom synthesis.
Solve supply chain risks with this 85%+ yield rhodium-catalyzed process. Cheap raw materials, high functional group tolerance, and scalable to 100MT/yr. Contact for COA/MSDS.
Discover how metal-free diselenomaleimide synthesis at room temperature reduces production costs and supply chain risks for pharmaceutical intermediates. High-yield, scalable solution for R&D and procurement teams.
Discover how this metal-free synthesis of 3-ethynyl imidazo[1,2-b]pyridazine reduces 8-step routes to 2 steps, cutting costs and eliminating metal residues for BCR-ABL kinase inhibitor manufacturing.
Discover catalyst-free oxadiazaborole synthesis with 5-min reaction time and >80% yield. Ideal for pharmaceutical intermediates with simplified purification and scalable production.
Solve tryptanthrin supply chain challenges with 98% yield copper-catalyzed synthesis. No oxidant, no anhydrous conditions. CDMO expertise for scalable production.
Discover a metal-free, low-cost synthesis method for 5-trifluoromethyl-1,2,4-triazole compounds. Eliminate heavy metal catalysts and reduce supply chain risks for your API manufacturing.
Discover metal-free, room-temperature synthesis of trifluoromethyl pyrazole compounds. Eliminate heavy metal catalysts, reduce EHS risks, and achieve 99%+ purity for pharmaceutical intermediates. Scale to 100 MT/yr.
Discover metal-free pyrazole synthesis with 77-99% yield. Eliminate catalyst costs, simplify purification, and ensure GMP-compliant production for your drug development.
Discover how reductive aminocarbonylation with molybdenum carbonyl dual role enables scalable chroman amide synthesis for pharmaceutical intermediates with 99%+ purity and broad functional group tolerance.